Nitin Jain, M.D. @CLLdoc Assistant Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX discusses Precautions and Suggestions Regarding Management of Adverse Events of BCR Signaling Inhibitors